Maryland prescription drug cost study finds 2 diabetes medicines have ‘affordability challenges’
Maryland’s Prescription Drug Affordability Board says it has identified two diabetes drugs that could be made more affordable for residents based on a cost study by the state agency. During a meeting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback